Pfizer?s Bextra Faces Its First Lawsuit

Legal Article Directory, Get Free Reprint Articles and Legal Content for your site with
article directory
54866 *recent articles in 509 categories Last article added 11/15/07
 
Article Categories
 
Reviews
 
Site Menu
 
Site Search


 
ArticlePros.com » Legal » Rights » Pfizer?s Bextra Faces Its First Lawsuit

  • Date: 2005-12-12
  • Author: Scott Montgomery
  • All articles by this author
  • Visit author's website
  • Pfizer?s Bextra Faces Its First Lawsuit


    Related Rights Articles

         For years, Merck has been under scrutiny for a number of drugs, most recently Vioxx. The recall of Vioxx has shares down by more than 40 percent and facing hundreds of lawsuits that could cost them billions of dollars. However, Merck is not alone in the scrutiny that this pharmaceutical company faces. Pfizer, the maker of Bextra and Celebrex, painkillers in the same family as Vioxx, is facing similar legal problems. The question being asked is whether Bextra and Celebrex increase the risk of heart attack and stroke.

    Although Pfizer has avoided much of the negative publicity in newspapers and radio as compared to
    Merck, the question still stands as to whether the problems with Vioxx extend to similar medicines taken by millions of consumers. Although these pharmaceutical companies claim to have drugs that relieve chronic arthritis pain without causing ulcers, what other side effects may be the result?

    Susan Raymond is filing a suit claiming her husband, age 46, died from a heart attack after taking Pfizer?s Bextra for only 10 months. Jerrold Parker, an attorney at Parker & Waichman in Great Neck, N.Y. will be representing her.

    Despite this incident, Pfizer challenges the negative effects that Bextra may have had, claiming that large, long-term studies demonstrate that although Bextra and Celebrex are in the same family of Cox-2 inhibitors, that they do not hold the same risk. Pfizer goes on to add that the two smaller studies that show risks associated with Bextra were limited to patients that had undergone open heart surgery and therefore, do not represent the risks to the average patient.

    At a major medical meeting, two leading researchers presented evidence that Bextra carries the same elevated risk of heart attack and stroke as other Cox-2 inhibitors. They criticized Pfizer for failing to notify the public of the scientific data relating to its risks. In turn, Pfizer said the findings were flawed. Although the effects of Bextra remain an immense debate, medical experts have and will continue to raise questions about the safety of Bextra and this class of medicines.

    More articles from this pro: http://www.ArticlePros.com/author.php?Scott Montgomery


    More on Legal and Rights can be found here.
     

    Get this article to go

    RSS | JScript | Email | HTML

     

    About the author

    Scott Montgomery, who represents the Montgomery Law Firm, LLC, investigates cases dealing with Bextra and its harmful side effects to consumers. If you or a loved one has been injured by Bextra you may have valuable legal rights. We will evaluate your case for free.
    http://www.montgomerylaw.org/bextra.php

    http://www.montgomerylaw.org/bextra.php

     
    Email options
       

    ** Check all that apply **

     

    This article has been accessed 1326 times since 2005-12-12.


    Home  •  Search  •  Add Your Own Article  •  RSS feeds  •  JavaScript Feeds  •   •  Set as Homepage  •  Add to Favourites
    Disclaimer: The information presented and opinions expressed herein are those of the authors
    and do not necessarily represent the views of ArticlePros.com and/or its partners.
    Copyright ArticlePros.com © 2005. All Rights Reserved